{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T17:15:50Z","timestamp":1788974150101,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T00:00:00Z","timestamp":1707091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.apsb.2024.02.002","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T02:42:12Z","timestamp":1708396932000},"page":"2646-2656","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Spirohypertones A and B as potent antipsoriatics: Tumor necrosis factor-\u03b1 inhibitors with unprecedented chemical architectures"],"prefix":"10.1016","volume":"14","author":[{"given":"Yulin","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiguang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengyi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changxing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2024.02.002_bib1","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2024.02.002_bib2","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/jdv.13854","article-title":"A systematic review of worldwide epidemiology of psoriasis","volume":"31","author":"Michalek","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.apsb.2024.02.002_bib3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2024.02.002_bib4","doi-asserted-by":"crossref","first-page":"J314","DOI":"10.1016\/j.jaut.2009.12.001","article-title":"Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis","volume":"34","author":"Chandran","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.apsb.2024.02.002_bib5","doi-asserted-by":"crossref","first-page":"13313","DOI":"10.3390\/ijms241713313","article-title":"Challenges and future trends in the treatment of psoriasis","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2024.02.002_bib6","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2147\/CCID.S420850","article-title":"Cellular mechanisms of psoriasis pathogenesis: a systemic review","volume":"16","author":"Wu","year":"2023","journal-title":"Clin Cosmet Invest Dermatol"},{"key":"10.1016\/j.apsb.2024.02.002_bib7","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1172\/JCI28508","article-title":"The IL-23\/IL-17 axis in inflammation","volume":"116","author":"Iwakura","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2024.02.002_bib8","doi-asserted-by":"crossref","first-page":"110646","DOI":"10.1016\/j.intimp.2023.110646","article-title":"Biomarkers and biologics related with psoriasis and psoriatic arthritis","volume":"122","author":"Gao","year":"2023","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.apsb.2024.02.002_bib9","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2024.02.002_bib10","doi-asserted-by":"crossref","first-page":"103575","DOI":"10.1016\/j.drudis.2023.103575","article-title":"Small-molecule modulators of tumor necrosis factor signaling","volume":"28","author":"Chedotal","year":"2023","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2024.02.002_bib11","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1021\/acs.chemrev.7b00551","article-title":"Research progress of polycyclic polyprenylated acylphloroglucinols","volume":"118","author":"Yang","year":"2018","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2024.02.002_bib12","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1021\/cr0500582","article-title":"Polycyclic polyprenylated acylphloroglucinols","volume":"106","author":"Ciochina","year":"2006","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2024.02.002_bib13","doi-asserted-by":"crossref","first-page":"112646","DOI":"10.1016\/j.ejmech.2020.112646","article-title":"Bicyclic polyprenylated acylphloroglucinols and their derivatives: structural modification, structure\u2013activity relationship, biological activity and mechanism of action","volume":"205","author":"Phang","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2024.02.002_bib14","doi-asserted-by":"crossref","first-page":"15852","DOI":"10.1002\/anie.201707069","article-title":"Polycyclic polyprenylated acylphloroglucinols: an emerging class of non-peptide-based MRSA- and VRE-active antibiotics","volume":"56","author":"Guttroff","year":"2017","journal-title":"Angew Chem Int Ed"},{"key":"10.1016\/j.apsb.2024.02.002_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.phytochem.2018.08.002","article-title":"Structural diversity and biological activities of phloroglucinol derivatives from Hypericum species","volume":"155","author":"Bridi","year":"2018","journal-title":"Phytochemistry"},{"key":"10.1016\/j.apsb.2024.02.002_bib16","doi-asserted-by":"crossref","first-page":"6478","DOI":"10.1021\/acs.joc.1c00319","article-title":"Hypaluton A, an immunosuppressive 3,4-nor-polycyclic polyprenylated acylphloroglucinol from Hypericum patulum","volume":"86","author":"Duan","year":"2021","journal-title":"J Org Chem"},{"key":"10.1016\/j.apsb.2024.02.002_bib17","doi-asserted-by":"crossref","first-page":"104902","DOI":"10.1016\/j.bioorg.2021.104902","article-title":"Discovery of nor-bicyclic polyprenylated acylphloroglucinols possessing diverse architectures with anti-hepatoma activities from Hypericum patulum","volume":"111","author":"Duan","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2024.02.002_bib18","doi-asserted-by":"crossref","first-page":"11438","DOI":"10.1039\/D1SC03356E","article-title":"Unprecedented polycyclic polyprenylated acylphloroglucinols with anti-Alzheimer\u2019s activity from St. John's wort","volume":"12","author":"Guo","year":"2021","journal-title":"Chem Sci"},{"key":"10.1016\/j.apsb.2024.02.002_bib19","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1021\/acs.jnatprod.9b01187","article-title":"Hypersonins A\u2212D, polycyclic polyprenylated acylphloroglucinols with a 1,2-seco-homoadamantane architecture from Hypericum wilsonii","volume":"83","author":"Xie","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2024.02.002_bib20","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1016\/j.cclet.2021.11.011","article-title":"Hyperbenzones A and B, two 1,2-seco and rearranged polycyclic polyprenylated acylphloroglucinols from Hypericum beanii","volume":"33","author":"Lu","year":"2022","journal-title":"Chin Chem Lett"},{"key":"10.1016\/j.apsb.2024.02.002_bib21","doi-asserted-by":"crossref","first-page":"6903","DOI":"10.1021\/acs.orglett.0c02434","article-title":"Hyperfols A and B: two highly modified polycyclic polyprenylated acylphloroglucinols from Hypericum perforatum","volume":"22","author":"Lou","year":"2020","journal-title":"Org Lett"},{"key":"10.1016\/j.apsb.2024.02.002_bib22","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.1021\/acs.joc.2c00503","article-title":"Norprzewalsone A, a rearranged polycyclic polyprenylated acylphloroglucinol with a spiro[cyclopentane-1,3\u2032-tricyclo[7.4.0.01,6]tridecane] core from Hypericum przewalskii","volume":"87","author":"Duan","year":"2022","journal-title":"J Org Chem"},{"key":"10.1016\/j.apsb.2024.02.002_bib23","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1039\/D3QO00752A","article-title":"Garcimultiflins A\u2013C, unusual polycyclic polyprenylated acylphloroglucinols from the pericarps of Garcinia multiflora as interleukin-1\u03b2 and pyroptosis inhibitors","volume":"10","author":"Cao","year":"2023","journal-title":"Org Chem Front"},{"key":"10.1016\/j.apsb.2024.02.002_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1039\/D2OB01851A","article-title":"Hyperpatone A, a polycyclic polyprenylated acylphloroglucinol with a rare 8\/6\/5\/6\/5 pentacyclic skeleton from Hypericum patulum","volume":"21","author":"Zhang","year":"2023","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.apsb.2024.02.002_bib25","doi-asserted-by":"crossref","first-page":"106005","DOI":"10.1016\/j.bioorg.2022.106005","article-title":"Diverse polycyclic polyprenylated acylphloroglucinols with anti-neuroinflammatory activity from Hypericum beanii","volume":"127","author":"Li","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2024.02.002_bib26","doi-asserted-by":"crossref","first-page":"104057","DOI":"10.1016\/j.arabjc.2022.104057","article-title":"Bioassay and UPLC\u2012Q-Orbitrap\u2012MS\/MS guided isolation of polycyclic polyprenylated acylphloroglucinols from St. John's wort and their neuroprotective activity","volume":"15","author":"Lou","year":"2022","journal-title":"Arab J Chem"},{"key":"10.1016\/j.apsb.2024.02.002_bib27","doi-asserted-by":"crossref","first-page":"113482","DOI":"10.1016\/j.phytochem.2022.113482","article-title":"Structurally diverse polycyclic polyprenylated acylphloroglucinols with protective effect on human vein endothelial cells injured by high-glucose from Hypericum acmosepalum N. Robson","volume":"205","author":"Wang","year":"2023","journal-title":"Phytochemistry"},{"key":"10.1016\/j.apsb.2024.02.002_bib28","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1021\/np900109y","article-title":"Acylphloroglucinol, biyouyanagiol, biyouyanagin B, and related spiro-lactones from Hypericum chinense","volume":"72","author":"Tanaka","year":"2009","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2024.02.002_bib29","doi-asserted-by":"crossref","first-page":"105074","DOI":"10.1016\/j.bioorg.2021.105074","article-title":"Polycyclic polyprenylated acylphloroglucinol congeners from Garcinia yunnanensis Hu with inhibitory effect on \u03b1-hemolysin production in Staphylococcus aureus","volume":"114","author":"Zheng","year":"2021","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2024.02.002_bib30","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1039\/C8OB00650D","article-title":"Hypermonins A and B, two 6-norpolyprenylated acylphloroglucinols with unprecedented skeletons from Hypericum monogynum","volume":"16","author":"Zeng","year":"2018","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.apsb.2024.02.002_bib31","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jdermsci.2022.05.006","article-title":"Tiamulin inhibits TNF-\u03b1 and alleviates psoriasis-like dermatitis","volume":"107","author":"Xiang","year":"2022","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.apsb.2024.02.002_bib32","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00216-023-04565-2","article-title":"Biosensor-based active ingredient recognition system for screening TNF-\u03b1 inhibitors from lotus leaves","volume":"415","author":"Guan","year":"2023","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/j.apsb.2024.02.002_bib33","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1016\/j.apsb.2022.12.009","article-title":"Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effects","volume":"13","author":"Wei","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.02.002_bib34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.apsb.2022.08.012","article-title":"Reprogrammed siTNF\u03b1\/neutrophil cytopharmaceuticals targeting inflamed joints for rheumatoid arthritis therapy","volume":"13","author":"Chen","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2024.02.002_bib35","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1021\/acs.analchem.9b05479","article-title":"An SPR-based membrane protein-targeted active ingredients recognition strategy: construction and implementation in ligand screening from herbal medicines","volume":"92","author":"Chen","year":"2020","journal-title":"Anal Chem"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524000418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383524000418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T12:08:04Z","timestamp":1716811684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383524000418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2211383524000418"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2024.02.002","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Spirohypertones A and B as potent antipsoriatics: Tumor necrosis factor-\u03b1 inhibitors with unprecedented chemical architectures","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2024.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}